Alvaro Moreno-Aspitia
Mayo College of Medicine
Multidisciplinary Breast Clinic
Mayo Clinic Florida
USA
Name/email consistency: high
- Clinical overview of sorafenib in breast cancer. Moreno-Aspitia, A. Future. Oncol (2010)
- Phase II trial of sorafenib in patients with metastatic breast cancer previously exposed to anthracyclines or taxanes: North Central Cancer Treatment Group and Mayo Clinic Trial N0336. Moreno-Aspitia, A., Morton, R.F., Hillman, D.W., Lingle, W.L., Rowland, K.M., Wiesenfeld, M., Flynn, P.J., Fitch, T.R., Perez, E.A. J. Clin. Oncol. (2009)
- Anthracycline- and/or taxane-resistant breast cancer: results of a literature review to determine the clinical challenges and current treatment trends. Moreno-Aspitia, A., Perez, E.A. Clin. Ther (2009)
- Assessment of platelet numbers and morphology in the peripheral blood smear. Moreno, A., Menke, D. Clin. Lab. Med. (2002)
- The prednisone dosage in the CHOP chemotherapy regimen for non-Hodgkin's lymphomas (NHL): is there a standard?. Moreno, A., Colon-Otero, G., Solberg, L.A. Oncologist (2000)